cbdsciencegroup.co.uk valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
Meta Tags
Title CBD Science Group
Description Helping Cancer Patients with Chronic Pain Creating Ethical Shareholder CBD Science is pioneering the development of cannabis-based treatments for cancer pain. CBD Science Group PLC is working with world-class physicians, and Britain’s official regulatory authorities to allow the legal availability of new pain
Keywords N/A
Server Information
WebSite cbdsciencegroup faviconcbdsciencegroup.co.uk
Host IP 109.106.240.17
Location Serbia
Related Websites
Site Rank
More to Explore
cbdsciencegroup.co.uk Valuation
US$457,513
Last updated: 2022-06-22 17:53:47

cbdsciencegroup.co.uk has Semrush global rank of 23,134,448. cbdsciencegroup.co.uk has an estimated worth of US$ 457,513, based on its estimated Ads revenue. cbdsciencegroup.co.uk receives approximately 52,790 unique visitors each day. Its web server is located in Serbia, with IP address 109.106.240.17. According to SiteAdvisor, cbdsciencegroup.co.uk is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$457,513
Daily Ads Revenue US$423
Monthly Ads Revenue US$12,670
Yearly Ads Revenue US$152,035
Daily Unique Visitors 3,520
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
cbdsciencegroup.co.uk. A 14398 IP: 109.106.240.17
cbdsciencegroup.co.uk. NS 86400 NS Record: ns1.dns-parking.com.
cbdsciencegroup.co.uk. NS 86400 NS Record: ns2.dns-parking.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 5 mx1.hostinger.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 10 aspmx2.googlemail.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 5 alt2.aspmx.l.google.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 10 mx2.hostinger.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 5 alt1.aspmx.l.google.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 1 aspmx.l.google.com.
cbdsciencegroup.co.uk. MX 3600 MX Record: 10 aspmx3.googlemail.com.
cbdsciencegroup.co.uk. TXT 3600 TXT Record: google-site-verification=l8lUg57-Tz90QXZP337rg_dxxr4Tpa3Gak_b-p6a5X4
cbdsciencegroup.co.uk. TXT 3600 TXT Record: v=spf1 include:_spf.mail.hostinger.com ~all
cbdsciencegroup.co.uk. TXT 3600 TXT Record: google-site-verification=koPb3W9zsm4qkNt8E__RQdzpj4FHqkkm2s-qZiywr04
HtmlToTextCheckTime:2022-06-22 17:53:47
Helping Cancer Patients with Chronic Pain Creating Ethical Shareholder Value Home About Us Business Strategy Key Stakeholders Clinical Study Real World Evidence Our Clinical Partners Advisory Board/Committee Invest News & Research Contact Us Menu Home About Us Business Strategy Key Stakeholders Clinical Study Real World Evidence Our Clinical Partners Advisory Board/Committee Invest News & Research Contact Us Our Mission Join us & help patients suffering today. “We will research, develop and make available commercially effective and affordable plant-based cannabinoid medicines specifically for treating patients suffering from cancer related pain in the UK.” Dr. Michael Raymont – Chairman CBD Science Group PLC About us Research Investors Media Contact Real World Evidence Multidimensional Evidence Generation and FDA Regulatory Decision Making Real World Evidence Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician Real World Evidence The Expanding Role of
HTTP Headers
HTTP/1.1 301 Moved Permanently
Connection: Keep-Alive
Keep-Alive: timeout=5, max=100
date: Sun, 24 Oct 2021 03:28:33 GMT
server: LiteSpeed
location: https://cbdsciencegroup.co.uk/
content-security-policy: upgrade-insecure-requests

HTTP/2 200 
x-powered-by: PHP/7.4.13
content-type: text/html; charset=UTF-8
date: Sun, 24 Oct 2021 03:28:35 GMT
server: LiteSpeed
content-security-policy: upgrade-insecure-requests
alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"